Of particular note, neither erythroid, myeloid, nor CD34+ cells in MDS patients exhibited significantly increased mitotic events versus controls, indicating that MDS marrow is not hyperproliferative. The gene discussed is CD34; the disease is myelodysplastic syndrome.